Skip to main navigation Skip to search Skip to main content

Prospective surveillance and risk reduction of cancer treatment-related lymphedema: Systematic review and meta-analysis

  • Jingyi Francess Ding
  • , Bashar Hasan
  • , Konstantinos Malandris
  • , Magdoleen H. Farah
  • , Apostolos Manolopoulos
  • , Pamela K. Ginex
  • , Allison B. Anbari
  • , Tarek Nayfeh
  • , Moutie Rami Rajjoub
  • , Raed Benkhadra
  • , Larry J. Prokop
  • , Rebecca L. Morgan
  • , M. Hassan Murad
  • Mayo Clinic Rochester, MN
  • Aristotle University of Thessaloniki
  • University of Missouri
  • West Penn Allegheny Health System
  • McMaster University

Research output: Contribution to journalReview articlepeer-review

12 Scopus citations

Abstract

PROBLEM IDENTIFICATION: Secondary lymphedema is a chronic condition that may result from cancer-related treatments. Evidence is emerging on prospective surveillance and risk reduction. LITERATURE SEARCH: Databases were systematically searched through April 1, 2019, for comparative studies evaluating interventions aiming to prevent lymphedema in patients with cancer. DATA EVALUATION: A random-effects model was used to perform meta-analysis, when appropriate. SYNTHESIS: A total of 26 studies (4,095 patients) were included, with 23 providing data sufficient for meta-analysis. Surveillance programs increased the likelihood of detecting lymphedema. Physiotherapy, exercise programs, and delayed exercise reduced the incidence of lymphedema. IMPLICATIONS FOR RESEARCH: Future research should standardize (a) evidence-based interventions to reduce the development of lymphedema and increase the likelihood of early detection and (b) outcome measures to build a body of evidence that leads to practice change.

Original languageEnglish
Pages (from-to)E161-E170
JournalOncology nursing forum
Volume47
Issue number5
DOIs
StatePublished - 2020

Keywords

  • Cancer treatment
  • Lymphedema
  • Meta-analysis
  • Systematic review

Fingerprint

Dive into the research topics of 'Prospective surveillance and risk reduction of cancer treatment-related lymphedema: Systematic review and meta-analysis'. Together they form a unique fingerprint.

Cite this